Foundry DelCOA Industry-Neutral Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1NFLX | NETFLIX INC | Communication Services | $290.47B | 16.26% |
2DIS | WALT DISNEY CO | Communication Services | $169.61B | 9.50% |
3BA | BOEING CO | Industrials | $168.72B | 9.45% |
4SNOW | SNOWFLAKE INC | Technology | $93.20B | 5.22% |
5NDAQ | NASDAQ INC | Financial Services | $51.83B | 2.90% |
6LYV | LIVE NATION ENTERTAINMENT INC | Communication Services | $42.45B | 2.38% |
7COIN | COINBASE GLOBAL INC | Financial Services | $41.40B | 2.32% |
8RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 2.22% |
9WDAY | WORKDAY INC | Technology | $35.76B | 2.00% |
10TKO | TKO GROUP HOLDINGS INC | Communication Services | $35.38B | 1.98% |
11MSTR | STRATEGY INC | Technology | $33.24B | 1.86% |
12DXCM | DEXCOM INC | Healthcare | $29.58B | 1.66% |
13ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 1.49% |
14CPRT | COPART INC | Industrials | $25.56B | 1.43% |
15VRSN | VERISIGN INC | Technology | $25.27B | 1.41% |
16MDB | MONGODB INC | Technology | $25.12B | 1.41% |
17MRNA | MODERNA INC | Healthcare | $24.53B | 1.37% |
18DLTR | DOLLAR TREE INC | Consumer Defensive | $24.20B | 1.36% |
19FSLR | FIRST SOLAR INC | Technology | $22.78B | 1.28% |
20UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 1.27% |
21ASTS | AST SPACEMOBILE INC | Technology | $22.43B | 1.26% |
22IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Basic Materials | $19.96B | 1.12% |
23APG | API GROUP CORP | Industrials | $17.38B | 0.97% |
24NWSA | NEWS CORP | Communication Services | $15.56B | 0.87% |
25CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $15.03B | 0.84% |
26DECK | DECKERS OUTDOOR CORP | Consumer Cyclical | $14.79B | 0.83% |
27BTSG | BRIGHTSPRING HEALTH SERVICES INC | Healthcare | $13.71B | 0.77% |
28PINS | PINTEREST INC | Communication Services | $13.00B | 0.73% |
29DKNG | DRAFTKINGS INC | Consumer Cyclical | $12.37B | 0.69% |
30AUR | AURORA INNOVATION INC | Technology | $11.88B | 0.67% |
31BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 0.64% |
32HUBS | HUBSPOT INC | Technology | $11.49B | 0.64% |
33HUT | HUT 8 CORP | Financial Services | $10.30B | 0.58% |
34GTLS | CHART INDUSTRIES INC | Industrials | $10.05B | 0.56% |
35CYTK | CYTOKINETICS INC | Healthcare | $9.98B | 0.56% |
36MSGS | MADISON SQUARE GARDEN SPORTS CORP | Communication Services | $9.56B | 0.54% |
37BMNR | BITMINE IMMERSION TECHNOLOGIES INC | Financial Services | $9.46B | 0.53% |
38LTH | LIFE TIME GROUP HOLDINGS INC | Consumer Cyclical | $9.38B | 0.53% |
39HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.52% |
40PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | $9.06B | 0.51% |
41TTC | TORO CO | Industrials | $8.99B | 0.50% |
42LUMN | LUMEN TECHNOLOGIES INC | Communication Services | $6.47B | 0.36% |
43SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $6.33B | 0.35% |
44IBP | INSTALLED BUILDING PRODUCTS INC | Consumer Cyclical | $6.16B | 0.34% |
45FBIN | FORTUNE BRANDS INNOVATIONS INC | Basic Materials | $6.14B | 0.34% |
46MYRG | MYR GROUP INC | Industrials | $6.10B | 0.34% |
47ERAS | ERASCA INC | Healthcare | $5.96B | 0.33% |
48LYFT | LYFT INC | Technology | $5.89B | 0.33% |
49CHDN | CHURCHILL DOWNS INC | Consumer Cyclical | $5.85B | 0.33% |
50ENPH | ENPHASE ENERGY INC | Technology | $5.48B | 0.31% |
51MTN | VAIL RESORTS INC | Consumer Cyclical | $5.27B | 0.30% |
52SPHR | SPHERE ENTERTAINMENT CO | Communication Services | $5.10B | 0.29% |
53DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 0.27% |
54PRIM | PRIMORIS SERVICES CORP | Industrials | $4.66B | 0.26% |
55KBR | KBR INC | Industrials | $4.45B | 0.25% |
56IPGP | IPG PHOTONICS CORP | Technology | $4.43B | 0.25% |
57VKTX | VIKING THERAPEUTICS INC | Healthcare | $4.31B | 0.24% |
58PI | IMPINJ INC | Technology | $4.21B | 0.24% |
59GPGI | GPGI INC | Industrials | $4.21B | 0.24% |
60ACLS | AXCELIS TECHNOLOGIES INC | Technology | $4.19B | 0.23% |
61PLNT | PLANET FITNESS INC | Consumer Cyclical | $4.16B | 0.23% |
62LION | LIONSGATE STUDIOS CORP | Communication Services | $4.03B | 0.23% |
63ICUI | ICU MEDICAL INC | Healthcare | $3.94B | 0.22% |
64DOCS | DOXIMITY INC | Healthcare | $3.94B | 0.22% |
65POWI | POWER INTEGRATIONS INC | Technology | $3.93B | 0.22% |
66TDS | TELEPHONE & DATA SYSTEMS INC | Communication Services | $3.90B | 0.22% |
67RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.21% |
68OLED | UNIVERSAL DISPLAY CORP | Technology | $3.75B | 0.21% |
69DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.21% |
70BATRA | ATLANTA BRAVES HOLDINGS INC | Communication Services | $3.63B | 0.20% |
71MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.56B | 0.20% |
72CNK | CINEMARK HOLDINGS INC | Communication Services | $3.55B | 0.20% |
73XXI | TWENTY ONE CAPITAL INC | Industrials | $3.48B | 0.19% |
74RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.19% |
75SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.18% |
76EEFT | EURONET WORLDWIDE INC | Technology | $3.10B | 0.17% |
77LEU | CENTRUS ENERGY CORP | Basic Materials | $3.07B | 0.17% |
78AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $3.02B | 0.17% |
79FRSH | FRESHWORKS INC | Technology | $3.01B | 0.17% |
80RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $2.88B | 0.16% |
81DAN | DANA INC | Consumer Cyclical | $2.87B | 0.16% |
82CLDX | CELLDEX THERAPEUTICS INC | Healthcare | $2.77B | 0.16% |
83VERA | VERA THERAPEUTICS INC | Healthcare | $2.76B | 0.15% |
84TNET | TRINET GROUP INC | Industrials | $2.74B | 0.15% |
85VISN | VISTANCE NETWORKS INC | Technology | $2.74B | 0.15% |
86OSW | ONESPAWORLD HOLDINGS LTD | Consumer Cyclical | $2.68B | 0.15% |
87IMNM | IMMUNOME INC | Healthcare | $2.53B | 0.14% |
88PGNY | PROGYNY INC | Healthcare | $2.50B | 0.14% |
89NRIX | NURIX THERAPEUTICS INC | Healthcare | $2.40B | 0.13% |
90BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.13% |
91AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $2.36B | 0.13% |
92BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.13% |
93IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | $2.23B | 0.13% |
94SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.12% |
95AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.12% |
96PRKS | UNITED PARKS & RESORTS INC | Consumer Cyclical | $2.13B | 0.12% |
97PPTA | PERPETUA RESOURCES CORP | Basic Materials | $2.11B | 0.12% |
98CDNA | CAREDX INC | Healthcare | $2.05B | 0.11% |
99SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.11% |
100AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 0.11% |
101CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $1.89B | 0.11% |
102NVCR | NOVOCURE LTD | Healthcare | $1.84B | 0.10% |
103SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.82B | 0.10% |
104ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.10% |
105ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.09% |
106TE | T1 ENERGY INC | Industrials | $1.63B | 0.09% |
107INVA | INNOVIVA INC | Healthcare | $1.60B | 0.09% |
108VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.09% |
109NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.09% |
110INSP | INSPIRE MEDICAL SYSTEMS INC | Healthcare | $1.46B | 0.08% |
111TRS | TRIMAS CORP | Consumer Cyclical | $1.46B | 0.08% |
112MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.08% |
113ARLO | ARLO TECHNOLOGIES INC | Basic Materials | $1.45B | 0.08% |
114YELP | YELP INC | Communication Services | $1.44B | 0.08% |
115AI | C3AI INC | Technology | $1.37B | 0.08% |
116CXM | SPRINKLR INC | Technology | $1.37B | 0.08% |
117BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.08% |
118FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.07% |
119CMP | COMPASS MINERALS INTERNATIONAL INC | Basic Materials | $1.24B | 0.07% |
120SDGR | SCHRODINGER INC | Healthcare | $1.14B | 0.06% |
121CRTO | CRITEO SA | Communication Services | $1.13B | 0.06% |
122UPWK | UPWORK INC | Industrials | $1.12B | 0.06% |
123EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.06% |
124CRSR | CORSAIR GAMING INC | Technology | $1.04B | 0.06% |
125LUCK | LUCKY STRIKE ENTERTAINMENT CORP | Consumer Cyclical | $1.01B | 0.06% |
126PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.06% |
127ACEL | ACCEL ENTERTAINMENT INC | Consumer Cyclical | $989M | 0.06% |
128KURA | KURA ONCOLOGY INC | Healthcare | $964M | 0.05% |
129ANNX | ANNEXON INC | Healthcare | $950M | 0.05% |
130REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.05% |
131MATW | MATTHEWS INTERNATIONAL CORP | Industrials | $857M | 0.05% |
132CYRX | CRYOPORT INC | Industrials | $832M | 0.05% |
133CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $777M | 0.04% |
134BBNX | BETA BIONICS INC | Healthcare | $771M | 0.04% |
135GDOT | GREEN DOT CORP | Financial Services | $760M | 0.04% |
136KRO | KRONOS WORLDWIDE INC | Basic Materials | $757M | 0.04% |
137IBTA | IBOTTA INC | Technology | $734M | 0.04% |
138AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.04% |
139MCS | MARCUS CORP | Communication Services | $708M | 0.04% |
140SPRY | ARS PHARMACEUTICALS INC | Healthcare | $695M | 0.04% |
141PKE | PARK AEROSPACE CORP | Industrials | $677M | 0.04% |
142RSVR | RESERVOIR MEDIA INC | Communication Services | $671M | 0.04% |
143SWBI | SMITH & WESSON BRANDS INC | Industrials | $665M | 0.04% |
144CNNE | CANNAE HOLDINGS INC | Consumer Cyclical | $657M | 0.04% |
145TREE | LENDINGTREE INC | Financial Services | $645M | 0.04% |
146ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.04% |
147PUBM | PUBMATIC INC | Technology | $591M | 0.03% |
148NGNE | NEUROGENE INC | Healthcare | $590M | 0.03% |
149ETD | ETHAN ALLEN INTERIORS INC | Consumer Cyclical | $580M | 0.03% |
150MLR | MILLER INDUSTRIES INC | Consumer Cyclical | $566M | 0.03% |
151EGY | VAALCO ENERGY INC | Energy | $553M | 0.03% |
152WNC | WABASH NATIONAL CORP | Industrials | $547M | 0.03% |
153PKOH | PARK OHIO HOLDINGS CORP | Industrials | $544M | 0.03% |
154ORN | ORION GROUP HOLDINGS INC | Industrials | $518M | 0.03% |
155ARVN | ARVINAS INC | Healthcare | $517M | 0.03% |
156SPIR | SPIRE GLOBAL INC | Industrials | $488M | 0.03% |
157SGMT | SAGIMET BIOSCIENCES INC | Healthcare | $479M | 0.03% |
158STRZ | STARZ ENTERTAINMENT CORP | Communication Services | $450M | 0.03% |
159TITN | TITAN MACHINERY INC | Industrials | $446M | 0.02% |
160SRTA | STRATA CRITICAL MEDICAL INC | Industrials | $446M | 0.02% |
161BNED | BARNES & NOBLE EDUCATION INC | Consumer Cyclical | $437M | 0.02% |
162CCRN | CROSS COUNTRY HEALTHCARE INC | Healthcare | $428M | 0.02% |
163ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.02% |
164CLFD | CLEARFIELD INC | Technology | $416M | 0.02% |
165MCFT | MASTERCRAFT BOAT HOLDINGS INC | Consumer Cyclical | $407M | 0.02% |
166ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | $400M | 0.02% |
167EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $394M | 0.02% |
168STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.02% |
169ABTC | AMERICAN BITCOIN CORP | Financial Services | $386M | 0.02% |
170UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.02% |
171ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.02% |
172MTRX | MATRIX SERVICE CO | Industrials | $342M | 0.02% |
173RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.02% |
174XPOF | XPONENTIAL FITNESS INC | Consumer Cyclical | $328M | 0.02% |
175VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.02% |
176VELO | VELO3D INC | Technology | $316M | 0.02% |
177MKTW | MARKETWISE INC | Technology | $314M | 0.02% |
178OSS | ONE STOP SYSTEMS INC | Technology | $313M | 0.02% |
179BKTI | BK TECHNOLOGIES CORP | Technology | $307M | 0.02% |
180FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.02% |
181ALCO | ALICO INC | Consumer Defensive | $304M | 0.02% |
182TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.02% |
183TSSI | TSS INC | Technology | $274M | 0.02% |
184AVNW | AVIAT NETWORKS INC | Technology | $269M | 0.02% |
185TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.01% |
186ALMU | AELUMA INC | Technology | $267M | 0.01% |
187SVCO | SILVACO GROUP INC | Technology | $260M | 0.01% |
188TBCH | TURTLE BEACH CORP | Technology | $258M | 0.01% |
189VNME | VENDOME ACQUISITION CORP I | Industrials | $254M | 0.01% |
190ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.01% |
191QUIK | QUICKLOGIC CORP | Technology | $237M | 0.01% |
192ALOT | ASTRONOVA INC | Technology | $222M | 0.01% |
193KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.01% |
194KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.01% |
195SRI | STONERIDGE INC | Consumer Cyclical | $197M | 0.01% |
196EAF | GRAFTECH INTERNATIONAL LTD | Industrials | $181M | 0.01% |
197KVHI | KVH INDUSTRIES INC | Technology | $178M | 0.01% |
198ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.01% |
199RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.01% |
200HOFT | HOOKER FURNISHINGS CORP | Consumer Cyclical | $152M | 0.01% |
201ACNT | ASCENT INDUSTRIES CO | Basic Materials | $138M | 0.01% |
202PMN | PROMIS NEUROSCIENCES INC | Healthcare | $136M | 0.01% |
203DMRC | DIGIMARC CORP | Technology | $133M | 0.01% |
204AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.01% |
205JYNT | JOINT CORP | Healthcare | $127M | 0.01% |
206VATE | INNOVATE CORP | Industrials | $123M | 0.01% |
207SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.01% |
208UFI | UNIFI INC | Consumer Cyclical | $118M | 0.01% |
209SSTI | SOUNDTHINKING INC | Technology | $111M | 0.01% |
210MHH | MASTECH DIGITAL INC | Industrials | $89M | 0.00% |
211GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.00% |
212RLYB | RALLYBIO CORP | Healthcare | $87M | 0.00% |
213CPHC | CANTERBURY PARK HOLDING CORP | Consumer Cyclical | $82M | 0.00% |
214DLHC | DLH HOLDINGS CORP | Industrials | $80M | 0.00% |
215LFVN | LIFEVANTAGE CORP | Consumer Defensive | $78M | 0.00% |
216SEAT | VIVID SEATS INC | Communication Services | $78M | 0.00% |
217ACET | ADICET BIO INC | Healthcare | $76M | 0.00% |
218ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $76M | 0.00% |
219BODI | BEACHBODY COMPANY INC | Communication Services | $75M | 0.00% |
220BGSF | BGSF INC | Industrials | $65M | 0.00% |
221BRID | BRIDGFORD FOODS CORP | Consumer Defensive | $59M | 0.00% |
222LNZA | LANZATECH GLOBAL INC | Industrials | $56M | 0.00% |
223TACT | TRANSACT TECHNOLOGIES INC | Technology | $54M | 0.00% |
224ACFN | ACORN ENERGY INC | Technology | $51M | 0.00% |
225TIL | INSTIL BIO INC | Healthcare | $50M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $1.79T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 92% toward Large, 62% toward Growth. +10% unclassified (23 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 225 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual34.4%Margin-9.4%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 225 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 16%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 21.6% | 7.7% |
| 3 yearsp.a. | 18.6% | -13.4% |
| 5 yearsp.a. | 12.8% | -4.7% |
| 10 yearsp.a. | 16.5% | -5.9% |
| Since inceptionp.a. | 9.0% | -5.3% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 7.8% | 6.1% |
| 2025 | 21.9% | -15.9% |
| 2024 | 13.3% | -36.0% |
| 2023 | 69.2% | 23.5% |
| 2022 | -32.8% | 11.0% |
| 2021 | 31.0% | 2.9% |
| 2020 | 35.2% | -15.3% |
| 2019 | 31.0% | -0.7% |
| 2018 | -10.0% | -8.8% |
| 2017 | 28.4% | -11.1% |
| 2016 | 9.1% | 3.2% |
| 2015 | 4.2% | 1.4% |
| 2014 | 15.9% | -1.9% |
| 2013 | 41.2% | -1.9% |
| 2012 | 16.6% | 10.6% |
| 2011 | 5.4% | 6.7% |
| 2010 | 25.2% | 13.6% |
| 2009 | 34.2% | -11.1% |
| 2008 | -39.2% | -5.5% |
| 2007 | 12.1% | -21.1% |
| 2006 | 13.8% | -9.1% |
| 2005 | 0.8% | -10.2% |
| 2004 | 2.6% | -8.5% |
| 2003 | 38.5% | 7.3% |
| 2002 | -36.9% | -22.3% |
| 2001 | -7.6% | 3.0% |
| 2000 | -31.9% | -8.0% |
| 1999 | 38.6% | -23.4% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry DelCOA Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a DelCOA signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.